Vildagliptin: the first innovative DDP-4 inhibitor
A review of the main stages of investigation undertaken by Novartis Pharmaceuticals in search of a new molecule for the treatment of type 2 diabetesmellitus, dipeptidyl peptidase-4 (DPP-4) inhibitor (Vildaglyptin). The data on specificity and selectivity of the action of this molecule are presenteda...
Saved in:
| Main Author: | |
|---|---|
| Format: | article |
| Language: | EN RU |
| Published: |
Endocrinology Research Centre
2010
|
| Subjects: | |
| Online Access: | https://doaj.org/article/9ab778ef5d4d43219fab7fe831ded6ca |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!